DRTS
Alpha Tau Medical Ltd
NASDAQ: DRTS · HEALTHCARE · BIOTECHNOLOGY
$7.37
+0.96% today
Updated 2026-04-29
Market cap
$712.00M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$3 – $9
Volume
0.3M
Alpha Tau Medical Ltd (DRTS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | — | $86000.00 | $776000.00 | $979000.00 | $1.07M | $1.10M | $1.23M |
| Gross profit | — | $-86000.00 | $-776000.00 | $-979000.00 | $-1.07M | $-1.10M | $-1.23M |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $6.64M | $7.54M | $11.45M | $20.89M | $26.42M | $27.02M | $30.83M |
| SG&A | $977000.00 | $1.41M | $1.86M | $10.27M | $7.33M | $6.67M | $8.36M |
| Operating income | $-8.01M | $-9.24M | $-13.79M | $-32.14M | $35.68M | $-36.04M | $-42.29M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $-7.94M | $-9.16M | $-13.01M | $-31.16M | $-28.03M | $-30.30M | $-41.06M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-8.01M | $-9.24M | $-13.79M | $-32.14M | $-29.10M | $-31.40M | $-42.29M |
| Interest expense | $1.28M | $217000.00 | $12.70M | $1.77M | $39000.00 | $344000.00 | $419000.00 |
| Income tax | $146000.00 | $158000.00 | $7000.00 | $20000.00 | $16000.00 | $6000.00 | — |
| Effective tax rate | -1.8% | -1.8% | -0.0% | -0.1% | -0.1% | -0.0% | 0.0% |
| Net income | $-8.46M | $-8.88M | $-27.27M | $-33.76M | $-29.16M | $-31.75M | $-42.63M |
| Net income growth (YoY) | — | -4.9% | -207.0% | -23.8% | +13.6% | -8.9% | -34.3% |
| Profit margin | — | — | — | — | — | — | — |